Shanghai Institute of Materia Medica; Chinese Academy of Sciences
发明人:
申请号：
EP13787305.5
公开号：
EP2848617A1
申请日:
2013.05.09
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention relates to a diarylo[a,g]quinolizidine compound of formula (I), enantiomer, diastereoisomer, racemate, mixture, pharmaceutically acceptable salt, crystalline hydrate or solvate thereof； the preparation method thereof, and uses thereof in preparing an experimental model drugs related to dopamine receptors and 5-HT receptors or a medicament for treating or preventing a disease related to dopamine receptors and 5-HT receptors.
